Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Société Européenne au capital de € 361 015 032 - 582 110 987 R.C.S Paris30 avenue Montaigne - 75008 Paris INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE...
-
HERNDON, Va., April 03, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) will host an audio webcast to review its first quarter 2026 results on Wednesday, April 29, 2026, at 8:00 a.m. Eastern Time. ...
-
Giant Sequoias Land Coalition shares 2025 Progress Report. GSLC treated 4,508 acres, planted 65,000+ trees, protecting these giants from climate threats.
-
VANCOUVER, British Columbia, April 03, 2026 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce that the United States Forest...
-
A new study finds 18% of mature giant sequoias killed by wildfire since 2015. Only 26% of groves show high resistance, with 13% at extinction risk.
-
BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...
-
CARMEL, Ind., April 03, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...
-
DALLAS, April 03, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...
-
WUHU, Cina, April 03, 2026 (GLOBE NEWSWIRE) -- Ad aprile 2026, LEPAS, il nuovo marchio di energie innovative del Chery Group, ospiterà a Milano un importante evento di gala dal titolo "Here’s to...
-
SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the...